Jubilant Pharmova saw the highest growth of 1.49% in patent filings and 0.24% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and grants by 0.24%. GlobalData’s DataBook provides a comprehensive analysis of Jubilant Pharmova’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Jubilant Pharmova has been focused on protecting inventions in United States(US) with seven publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 58% of filings. The United States(US), European Patent Office(EPO), Denmark(DK), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Jubilant Pharmova is filings its patents. Among the top granted patent authorities, Jubilant Pharmova has 67% of its grants in European Patent Office(EPO) and 33% in Finland(FI).
Roche and Johnson & Johnson could be the strongest competitors for Jubilant Pharmova
Patents related to rare diseases and healthtech lead Jubilant Pharmova's portfolio
Jubilant Pharmova has the highest number of patents in rare diseases followed by, healthtech and remote patient monitoring. For rare diseases, nearly 50% of patents were filed and 100% of patents were granted in Q2 2024.
Rheumatoid arthritis related patents lead Jubilant Pharmova portfolio followed by multiple sclerosis, and lupus erythematosus
Jubilant Pharmova has highest number of patents in rheumatoid arthritis followed by multiple sclerosis, lupus erythematosus, systemic lupus erythematosus, and psoriasis. For rheumatoid arthritis, nearly 4% of patents were filed and 7% of patents were granted in Q2 2024.
For comprehensive analysis of Jubilant Pharmova's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
